Linked Life Data

14757687

Source:http://linkedlifedata.com/resource/pubmed/id/14757687

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2004-2-24
pubmed:abstractText
The clinical benefits of insulin previously observed in acute ST-segment-elevation myocardial infarction (STEMI) may be partially explained by an anti-inflammatory effect. We assessed this potential effect of insulin in STEMI patients treated with fibrinolytics.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase, MB Form, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/NADPH Oxidase, http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Serum Amyloid A Protein, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/neutrophil cytosolic factor 1, http://linkedlifedata.com/resource/pubmed/chemical/reteplase
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
24
pubmed:volume
109
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
849-54
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:14757687-Aged, pubmed-meshheading:14757687-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:14757687-Blood Glucose, pubmed-meshheading:14757687-C-Reactive Protein, pubmed-meshheading:14757687-Comorbidity, pubmed-meshheading:14757687-Creatine Kinase, pubmed-meshheading:14757687-Creatine Kinase, MB Form, pubmed-meshheading:14757687-Drug Therapy, Combination, pubmed-meshheading:14757687-Electrocardiography, pubmed-meshheading:14757687-Female, pubmed-meshheading:14757687-Fibrinolytic Agents, pubmed-meshheading:14757687-Humans, pubmed-meshheading:14757687-Inflammation, pubmed-meshheading:14757687-Insulin, pubmed-meshheading:14757687-Isoenzymes, pubmed-meshheading:14757687-Male, pubmed-meshheading:14757687-Middle Aged, pubmed-meshheading:14757687-Myocardial Infarction, pubmed-meshheading:14757687-NADPH Oxidase, pubmed-meshheading:14757687-Phosphoproteins, pubmed-meshheading:14757687-Plasminogen Activator Inhibitor 1, pubmed-meshheading:14757687-Recombinant Proteins, pubmed-meshheading:14757687-Serum Amyloid A Protein, pubmed-meshheading:14757687-Thrombolytic Therapy, pubmed-meshheading:14757687-Tissue Plasminogen Activator, pubmed-meshheading:14757687-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction.
pubmed:affiliation
Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, and Kaleida Health, Buffalo, NY 14209, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't